Saturday 17 October 2026
Export HIMS’s income statement to Excel — free account
Hims & Hers Health, Inc.
HIMS Healthcare Drug Manufacturers Specialty & Generic
Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024. In the quarter to June 2026, revenue grew 38.3%, EPS fell 294.7%, free cash flow grew 5.09% and total debt rose 40.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
28.07
1.31
−4.46%
Follow HIMS
| Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 4 | — | 6 | 6 | 6 | 4 |
P/E ratio |
198.00 | 198.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 41.69 | 56.96 |
Altman Z-Score |
0.28 | 13.37 | 0.97 | 17.49 | 7.90 | 14.16 | 14.46 | 12.57 | 15.76 | 4.10 |
P/S ratio |
0.00 | 0.00 | 3.47 | 3.73 | 4.50 | 4.64 | 2.45 | 2.31 | 3.54 | 3.11 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 35.87 | 24.93 | 98.76 |
Altman Z″-Score (non-manufacturers) |
(2.31) | 6.88 | (0.73) | 1.22 | 3.06 | 3.44 | 4.69 | 3.17 | 3.26 | 1.62 |
P/Operating CF |
(1,443.68) | (1,443.68) | (1,918.84) | (2,060.78) | (394.02) | (406.05) | (192.37) | 91.80 | 60.44 | 119.14 |
P/B ratio |
0.25 | 0.25 | 0.00 | 0.00 | 3.66 | 3.77 | 4.15 | 5.87 | 10.95 | 13.50 |
Price to Tangible BV |
0.25 | 0.25 | 0.00 | 0.00 | 6.18 | 6.37 | 7.22 | 9.41 | 16.29 | 109.86 |
EV/Sales |
0.00 | 0.00 | 2.80 | 3.05 | 3.61 | 3.74 | 2.12 | 2.06 | 3.33 | 3.28 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 65.97 | 47.35 |
EV/Operating CF |
0.00 | 0.00 | (167.79) | (183.20) | (28.49) | (29.57) | (42.09) | 24.49 | 19.61 | 25.66 |
EV/FCF |
0.00 | 0.00 | (98.66) | (107.72) | (27.81) | (28.87) | (38.18) | 31.99 | 23.51 | 104.10 |
Quick Ratio |
1.54 | 6.58 | 6.58 | 3.12 | 3.12 | 3.75 | 3.75 | 2.50 | 1.36 | 1.43 |
Current Ratio |
1.69 | 7.17 | 7.43 | 3.41 | 3.41 | 4.52 | 4.52 | 3.00 | 1.79 | 1.90 |
Net Debt/EBITDA |
0.02 | 7.11 | 7.46 | 0.00 | 2.28 | 0.00 | 2.94 | 8.62 | (4.02) | 2.43 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 45.14% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.80 |
Asset Turnover |
0.81 | 0.00 | 0.92 | 0.00 | 1.01 | 0.00 | 1.34 | 2.16 | 2.57 | 1.64 |
Operating CF/Net income |
1.04 | 0.14 | 0.14 | 0.32 | 0.32 | 0.40 | 0.40 | (3.12) | 1.99 | 2.34 |
Capex/Depreciation |
(2.37) | 0.00 | (1.02) | 0.00 | (0.13) | 0.00 | (0.36) | (4.50) | (3.27) | (3.97) |
Interest Coverage |
(201.66) | (5.50) | (1,514.40) | — | — | — | — | — | — | — |
| (75.36%) | 0.00% | 25.54% | 0.00% | (114.69%) | 0.00% | (20.32%) | (7.18%) | 30.71% | 25.23% | |
| (70.39%) | 0.00% | (11.20%) | 0.00% | (39.93%) | 0.00% | (16.69%) | (5.83%) | 21.94% | 8.97% | |
ROIC |
(1,332.74%) | 0.00% | 0.00% | 0.00% | (82.32%) | 0.00% | (32.50%) | (14.96%) | 21.92% | 7.05% |
Return on Tangible Assets |
(10,622.64%) | (19.29%) | (18.51%) | 0.00% | (56.46%) | (37.84%) | (36.52%) | (11.07%) | 49.13% | 19.01% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 7.55% | 0.00% | 8.23% | 0.00% | 5.55% | 5.53% | 5.34% | 6.36% |
Selling, General and Administrative Expense of Revenue |
144.16% | 83.05% | 57.15% | 116.03% | 91.79% | 89.15% | 70.37% | 66.09% | 57.34% | 50.78% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.33 | 0.33 | 0.36 | 0.36 | 0.29 | 0.22 | 0.22 |
Share Based Compensation of Revenue |
9.72% | 0.00% | 3.92% | 0.00% | 24.72% | 0.00% | 8.13% | 7.58% | 6.25% | 5.76% |
Graham Net Nets |
(0.13) | (0.13) | (0.30) | (0.28) | 0.15 | 0.15 | 0.13 | 0.08 | 0.03 | (0.12) |
Graham Number |
0.00 | 0.00 | 6.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.37 | 5.55 |
Earnings Yield |
0.51% | 0.51% | (3.51%) | (3.27%) | (9.47%) | (9.19%) | (5.06%) | (1.18%) | 2.40% | 1.76% |
Free Cash Flow Yield |
0.00% | 0.00% | (0.82%) | (0.76%) | (2.88%) | (2.80%) | (2.26%) | 2.79% | 4.01% | 1.01% |
Revenue per Share |
2.38 | 4.21 | 4.21 | 1.46 | 1.46 | 2.58 | 2.58 | 4.17 | 6.84 | 10.44 |
Operating CF per Share |
(2.15) | (0.07) | (0.07) | (0.18) | (0.18) | (0.13) | (0.13) | 0.35 | 1.16 | 1.33 |
Capex per Share |
(0.01) | 0.00 | (0.05) | 0.00 | 0.00 | 0.00 | (0.01) | (0.08) | (0.19) | (1.00) |
Free Cash Flow per Share |
(2.16) | (0.07) | (0.12) | (0.18) | (0.19) | (0.13) | (0.14) | 0.27 | 0.97 | 0.33 |
Cash per Share |
0.04 | 2.83 | 2.83 | 1.32 | 1.32 | 0.88 | 0.88 | 1.06 | 1.39 | 2.57 |
Shareholders Equity per Share |
0.14 | 2.92 | (4.15) | 1.79 | 1.79 | 1.52 | 1.52 | 1.64 | 2.21 | 2.40 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.14 | 2.92 | (4.15) | 1.79 | 1.79 | 1.52 | 1.52 | 1.64 | 2.21 | 2.40 |
Free Cash Flow |
(75.17) | (2.48) | (4.22) | (34.41) | (35.24) | (26.53) | (29.24) | 56.26 | 209.43 | 73.96 |
Working Capital |
0.68 | 93.93 | 97.86 | 190.68 | 190.68 | 168.65 | 168.65 | 176.59 | 174.46 | 363.21 |
Capital Expenditures |
(0.31) | (4.23) | (1.74) | (5.01) | (0.83) | (7.25) | (2.71) | (17.22) | (41.65) | (226.04) |
Net Current Asset Value |
(198.11) | 93.55 | (152.49) | 183.94 | 183.94 | 162.00 | 162.00 | 167.90 | 165.01 | (846.14) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 79.54 | 72.90 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.10 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 84.35 | 69.16 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.51 | 0.68 | 0.11 | 0.16 | 0.18 |
Cash ROIC |
(1,154.71%) | (1.22%) | 9.03% | 0.00% | (6.06%) | 0.00% | (5.95%) | 9.96% | 26.95% | 3.54% |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
2,051.51 | 0.00 | 9.72 | 0.00 | 4.86 | 0.00 | 4.55 | 4.16 | 4.52 | 5.24 |
Inventory Turnover |
0.00 | 0.00 | 11.09 | 0.00 | 7.88 | 0.00 | 6.73 | 7.13 | 6.98 | 8.50 |
Average Days of Payables |
0.18 | 72.94 | 74.90 | 100.32 | 106.38 | 94.00 | 99.94 | 100.10 | 109.70 | 85.14 |
Days of Inventory on Hand |
0.00 | 32.04 | 32.90 | 69.25 | 73.44 | 62.63 | 66.59 | 52.21 | 77.51 | 47.61 |
Average Receivables |
— | 2.16 | — | 2.16 | — | 3.40 | — | — | — | — |
Average Payables |
0.02 | 4.04 | 4.04 | 13.85 | 13.85 | 26.00 | 26.00 | 37.72 | 67.13 | 117.23 |
Average Inventory |
— | 3.54 | 3.54 | 8.55 | 8.55 | 17.56 | 17.56 | 22.01 | 43.45 | 72.28 |
Average Assets |
102.38 | 161.73 | 161.73 | 269.64 | 269.64 | 393.46 | 393.46 | 403.76 | 574.36 | 1,431.12 |
Average Common Equity |
95.62 | (70.94) | (70.94) | 93.87 | 93.87 | 323.18 | 323.18 | 327.89 | 410.37 | 508.82 |
Columns are period end dates